{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T02:22:33Z","timestamp":1781835753188,"version":"3.54.5"},"reference-count":35,"publisher":"e-Century Publishing Corporation","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/wzrr7919","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T07:24:09Z","timestamp":1764228249000},"page":"8757-8766","source":"Crossref","is-referenced-by-count":2,"title":["Regulation of ulcerative colitis progression by ferroptosis pathway genes: HSP90AA1, SNCA, TLR4, and PTGS2"],"prefix":"10.62347","volume":"17","author":[{"given":"Xueming","family":"Gai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3238\/arztebl.2020.0564","article-title":"Ulcerative colitis-diagnostic and therapeutic algorithms","volume":"117","author":"Kucharzik","year":"2020","unstructured":"Kucharzik T, Koletzko S, Kannengiesser K and Dignass A. Ulcerative colitis-diagnostic and therapeutic algorithms. Dtsch Arztebl Int 2020; 117: 564-574.","journal-title":"Dtsch Arztebl Int"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Porter RJ, Kalla R and Ho GT. Ulcerative colitis: recent advances in the understanding of disease pathogenesis. F1000Res 2020; 9: F1000 Faculty Rev-294.","DOI":"10.12688\/f1000research.20805.1"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"103017","DOI":"10.1016\/j.autrev.2021.103017","article-title":"The influence of cytokines on the complex pathology of ulcerative colitis","volume":"21","author":"Nakase","year":"2022","unstructured":"Nakase H, Sato N, Mizuno N and Ikawa Y. The influence of cytokines on the complex pathology of ulcerative colitis. Autoimmun Rev 2022; 21: 103017.","journal-title":"Autoimmun Rev"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/ecco-jcc\/jjaa036","article-title":"Ulcerative colitis and cytomegalovirus infection: from A to Z","volume":"14","author":"Mourad","year":"2020","unstructured":"Mourad FH, Hashash JG, Kariyawasam VC and Leong RW. Ulcerative colitis and cytomegalovirus infection: from A to Z. J Crohns Colitis 2020; 14: 1162-1171.","journal-title":"J Crohns Colitis"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.tips.2024.08.003","article-title":"Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments","volume":"45","author":"Wangchuk","year":"2024","unstructured":"Wangchuk P, Yeshi K and Loukas A. Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments. Trends Pharmacol Sci 2024; 45: 892-903.","journal-title":"Trends Pharmacol Sci"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"103751","DOI":"10.1016\/j.ebiom.2021.103751","article-title":"MUC2 and related bacterial factors: therapeutic targets for ulcerative colitis","volume":"74","author":"Yao","year":"2021","unstructured":"Yao D, Dai W, Dong M, Dai C and Wu S. MUC2 and related bacterial factors: therapeutic targets for ulcerative colitis. EBioMedicine 2021; 74: 103751.","journal-title":"EBioMedicine"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.gtc.2020.08.003","article-title":"Assessing severity of disease in patients with ulcerative colitis","volume":"49","author":"Pabla","year":"2020","unstructured":"Pabla BS and Schwartz DA. Assessing severity of disease in patients with ulcerative colitis. Gastroenterol Clin North Am 2020; 49: 671-688.","journal-title":"Gastroenterol Clin North Am"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Krugliak Cleveland N, Torres J and Rubin DT. What does disease progression look like in ulcerative colitis, and how might it be prevented? Gastroenterology 2022; 162: 1396-1408.","DOI":"10.1053\/j.gastro.2022.01.023"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1200111","DOI":"10.3389\/fimmu.2023.1200111","article-title":"The role of Nrf2 in the pathogenesis and treatment of ulcerative colitis","volume":"14","author":"Peng","year":"2023","unstructured":"Peng S, Shen L, Yu X, Zhang L, Xu K, Xia Y, Zha L, Wu J and Luo H. The role of Nrf2 in the pathogenesis and treatment of ulcerative colitis. Front Immunol 2023; 14: 1200111.","journal-title":"Front Immunol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1013900","DOI":"10.3389\/fimmu.2022.1013900","article-title":"Oral manifestations serve as potential signs of ulcerative colitis: a review","volume":"13","author":"Li","year":"2022","unstructured":"Li C, Wu Y, Xie Y, Zhang Y, Jiang S, Wang J, Luo X and Chen Q. Oral manifestations serve as potential signs of ulcerative colitis: a review. Front Immunol 2022; 13: 1013900.","journal-title":"Front Immunol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"998470","DOI":"10.3389\/fimmu.2022.998470","article-title":"Identification and exploration of pharmacological pyroptosis-related biomarkers of ulcerative colitis","volume":"13","author":"Chen","year":"2022","unstructured":"Chen K, Shang S, Yu S, Cui L, Li S and He N. Identification and exploration of pharmacological pyroptosis-related biomarkers of ulcerative colitis. Front Immunol 2022; 13: 998470.","journal-title":"Front Immunol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.3748\/wjg.v27.i22.2963","article-title":"Mucosal lesions of the upper gastrointestinal tract in patients with ulcerative colitis: a review","volume":"27","author":"Sun","year":"2021","unstructured":"Sun Y, Zhang Z, Zheng CQ and Sang LX. Mucosal lesions of the upper gastrointestinal tract in patients with ulcerative colitis: a review. World J Gastroenterol 2021; 27: 2963-2978.","journal-title":"World J Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"116722","DOI":"10.1016\/j.biopha.2024.116722","article-title":"Ferroptosis in ulcerative colitis: potential mechanisms and promising therapeutic targets","volume":"175","author":"Long","year":"2024","unstructured":"Long D, Mao C, Huang Y, Xu Y and Zhu Y. Ferroptosis in ulcerative colitis: potential mechanisms and promising therapeutic targets. Biomed Pharmacother 2024; 175: 116722.","journal-title":"Biomed Pharmacother"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Lee KE, Faye AS, Vermeire S and Shen B. Perioperative management of ulcerative colitis: a systematic review. Dis Colon Rectum 2022; 65: S5-S19.","DOI":"10.1097\/DCR.0000000000002588"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1080\/17474124.2024.2397650","article-title":"Practical management of mild-to-moderate ulcerative colitis: an international expert consensus","volume":"18","author":"D&#x2019","year":"2024","unstructured":"D’Amico F, Magro F, Dignass A, Al Awadhi S, Gutierrez Casbas A, Queiroz NSF, Rydzewska G, Duk Ye B, Ran Z, Hart A, Jairath V, Fiorino G, Peyrin-Biroulet L and Danese S. Practical management of mild-to-moderate ulcerative colitis: an international expert consensus. Expert Rev Gastroenterol Hepatol 2024; 18: 421-430.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1080\/14712598.2020.1792882","article-title":"Ustekinumab for treating ulcerative colitis: an expert opinion","volume":"20","author":"Biancone","year":"2020","unstructured":"Biancone L, Ardizzone S, Armuzzi A, Castiglione F, D’Inca R, Danese S, Daperno M, Gionchetti P, Rizzello F, Scribano ML, Vecchi M and Orlando A. Ustekinumab for treating ulcerative colitis: an expert opinion. Expert Opin Biol Ther 2020; 20: 1321-1329.","journal-title":"Expert Opin Biol Ther"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/MOG.0000000000001023","article-title":"A practical guide to selecting and using new ulcerative colitis therapies","volume":"40","author":"Nagaraj","year":"2024","unstructured":"Nagaraj T, Shinn J and De Felice K. A practical guide to selecting and using new ulcerative colitis therapies. Curr Opin Gastroenterol 2024; 40: 235-242.","journal-title":"Curr Opin Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1162458","DOI":"10.3389\/fimmu.2023.1162458","article-title":"Unveiling the key genes, environmental toxins, and drug exposures in modulating the severity of ulcerative colitis: a comprehensive analysis","volume":"14","author":"Wang","year":"2023","unstructured":"Wang Y, Zhuang H, Jiang XH, Zou RH, Wang HY and Fan ZN. Unveiling the key genes, environmental toxins, and drug exposures in modulating the severity of ulcerative colitis: a comprehensive analysis. Front Immunol 2023; 14: 1162458.","journal-title":"Front Immunol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.3390\/nu14051069","article-title":"Taxifolin alleviates DSS-induced ulcerative colitis by acting on gut microbiome to produce butyric acid","volume":"14","author":"Li","year":"2022","unstructured":"Li W, Zhang L, Xu Q, Yang W, Zhao J, Ren Y, Yu Z and Ma L. Taxifolin alleviates DSS-induced ulcerative colitis by acting on gut microbiome to produce butyric acid. Nutrients 2022; 14: 1069.","journal-title":"Nutrients"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Abbas A, Di Fonzo DMP, Wetwittayakhlang P, Al-Jabri R, Lakatos PL and Bessissow T. Management of ulcerative colitis: where are we at and where are we heading? Expert Rev Gastroenterol Hepatol 2024; 18: 567-574.","DOI":"10.1080\/17474124.2024.2422370"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Zhou Y, Zhu F, Jing D, Wang Q and Zhou G. Ulcerative colitis and thrombocytosis: case report and literature review. Medicine (Baltimore) 2023; 102: e33784.","DOI":"10.1097\/MD.0000000000033784"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1089622","DOI":"10.3389\/fimmu.2023.1089622","article-title":"Exploration of the shared pathways and common biomarker PAN3 in ankylosing spondylitis and ulcerative colitis using integrated bioinformatics analysis","volume":"14","author":"Zhang","year":"2023","unstructured":"Zhang M, Zhou J, Wang H, He L, Wang J, Yang X and Zhong X. Exploration of the shared pathways and common biomarker PAN3 in ankylosing spondylitis and ulcerative colitis using integrated bioinformatics analysis. Front Immunol 2023; 14: 1089622.","journal-title":"Front Immunol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"101606","DOI":"10.1016\/j.disamonth.2023.101606","article-title":"Ulcerative colitis: addressing the manifestations, the role of fecal microbiota transplantation as a novel treatment option and other therapeutic updates","volume":"69","author":"Marsool","year":"2023","unstructured":"Marsool MDM, Vora N, Marsool ADM, Pati S, Narreddy M, Patel P, Gadam S and Prajjwal P. Ulcerative colitis: addressing the manifestations, the role of fecal microbiota transplantation as a novel treatment option and other therapeutic updates. Dis Mon 2023; 69: 101606.","journal-title":"Dis Mon"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1080\/14712598.2024.2369189","article-title":"Management of proctitis in ulcerative colitis and the place of biological therapies","volume":"24","author":"De Deo","year":"2024","unstructured":"De Deo D, Dal Buono A, Gabbiadini R, Spaggiari P, Busacca A, Masoni B, Ferretti S, Bezzio C and Armuzzi A. Management of proctitis in ulcerative colitis and the place of biological therapies. Expert Opin Biol Ther 2024; 24: 443-453.","journal-title":"Expert Opin Biol Ther"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1055\/a-1482-9273","article-title":"Steroid-refractory ulcerative colitis: a critical review of national and international guideline recommendations","volume":"59","author":"Stange","year":"2021","unstructured":"Stange EF. Steroid-refractory ulcerative colitis: a critical review of national and international guideline recommendations. Z Gastroenterol 2021; 59: 1214-1223.","journal-title":"Z Gastroenterol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/ueg2.12215","article-title":"Ulcerative colitis, a transmural disease requiring an accurate IUS assessment in the current treat-to-target era","volume":"10","author":"Dolinger","year":"2022","unstructured":"Dolinger M and Verstockt B. Ulcerative colitis, a transmural disease requiring an accurate IUS assessment in the current treat-to-target era. United European Gastroenterol J 2022; 10: 247-248.","journal-title":"United European Gastroenterol J"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.gtc.2020.08.006","article-title":"Fecal Microbiota Transplantation for ulcerative colitis","volume":"49","author":"Cheng","year":"2020","unstructured":"Cheng YW and Fischer M. Fecal Microbiota Transplantation for ulcerative colitis. are we ready for primetime? Gastroenterol Clin North Am 2020; 49: 739-752.","journal-title":"are we ready for primetime? Gastroenterol Clin North Am"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Magro F, Estevinho MM and Feakins R. Inflammation of the appendix in ulcerative colitis - Does it have a predictive value? United European Gastroenterol J 2021; 9: 1107-1108.","DOI":"10.1002\/ueg2.12181"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3748\/wjg.v27.i10.908","article-title":"The Use of granulocyte\/monocytapheresis in ulcerative colitis: a practical review from a European perspective","volume":"27","author":"Domenech","year":"2021","unstructured":"Domenech E, Grifols JR, Akbar A and Dignass AU. The Use of granulocyte\/monocytapheresis in ulcerative colitis: a practical review from a European perspective. World J Gastroenterol 2021; 27: 908-918.","journal-title":"World J Gastroenterol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/MOG.0000000000000637","article-title":"The management of the hospitalized ulcerative colitis patient: the medical-surgical conundrum","volume":"36","author":"Levy","year":"2020","unstructured":"Levy LC, Coburn ES, Choi S and Holubar SD. The management of the hospitalized ulcerative colitis patient: the medical-surgical conundrum. Curr Opin Gastroenterol 2020; 36: 265-276.","journal-title":"Curr Opin Gastroenterol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11894-021-00820-7","article-title":"The management of the hospitalized ulcerative colitis patient, the medical-surgical conundrum","volume":"23","author":"Carvello","year":"2021","unstructured":"Carvello M, Watfah J and Spinelli A. The management of the hospitalized ulcerative colitis patient, the medical-surgical conundrum. Curr Gastroenterol Rep 2021; 23: 25.","journal-title":"Curr Gastroenterol Rep"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"4216","DOI":"10.2174\/0929867329666211227121321","article-title":"The significant role of nutraceutical compounds in ulcerative colitis treatment","volume":"29","author":"Maio","year":"2022","unstructured":"Maio AC, Basile G, Iacopetta D, Catalano A, Ceramella J, Cafaro D, Saturnino C and Sinicropi MS. The significant role of nutraceutical compounds in ulcerative colitis treatment. Curr Med Chem 2022; 29: 4216-4234.","journal-title":"Curr Med Chem"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/17474124.2022.2048817","article-title":"Role of vitamin D in ulcerative colitis: an update on basic research and therapeutic applications","volume":"16","author":"Wang","year":"2022","unstructured":"Wang H, He X, Liang S and Chen X. Role of vitamin D in ulcerative colitis: an update on basic research and therapeutic applications. Expert Rev Gastroenterol Hepatol 2022; 16: 251-264.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1111\/apt.17731","article-title":"Systematic review: scores used to predict outcomes in acute severe ulcerative colitis","volume":"58","author":"Kayal","year":"2023","unstructured":"Kayal M, Meringer H, Martin L and Colombel JF. Systematic review: scores used to predict outcomes in acute severe ulcerative colitis. Aliment Pharmacol Ther 2023; 58: 974-983.","journal-title":"Aliment Pharmacol Ther"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1111\/apt.16925","article-title":"Editorial: is older-onset ulcerative colitis more severe or less aggressively managed? Authors’ reply","volume":"55","author":"Okabayashi","year":"2022","unstructured":"Okabayashi S, Yamazaki H, Matsuoka K, Yamamoto Y and Kobayashi T. Editorial: is older-onset ulcerative colitis more severe or less aggressively managed? Authors’ reply. Aliment Pharmacol Ther 2022; 55: 1352-1353.","journal-title":"Aliment Pharmacol Ther"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/11\/ajtr0164654.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:15:49Z","timestamp":1779344149000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/11\/ajtr0164654.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":35,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/wzrr7919","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}